Table of Contents

December 1, 2021; Volume 62,Issue 12

  1. Ma, Yilong

    1. Dynamic <sup>18</sup>F-FPCIT PET: Quantification of Parkinson Disease Metabolic Networks and Nigrostriatal Dopaminergic Dysfunction in a Single Imaging Session
      Dynamic 18F-FPCIT PET: Quantification of Parkinson Disease Metabolic Networks and Nigrostriatal Dopaminergic Dysfunction in a Single Imaging Session
      Shichun Peng, Chris Tang, Katharina Schindlbeck, Yaacov Rydzinski, Vijay Dhawan, Phoebe G. Spetsieris, Yilong Ma and David Eidelberg
      Journal of Nuclear Medicine December 1, 2021, 62 (12) 1775-1782; DOI: https://doi.org/10.2967/jnumed.120.257345

  2. Mahvash, Armeen

    1. Radioembolization Versus Bland or Chemoembolization for Liver-Dominant Neuroendocrine Tumors: Is It an Either/Or Question?
      Strosberg Jonathan, Ghassan El-Haddad, Taymeyah Al-Toubah, Diane Reidy-Lagunes, Etay Ziv, Armeen Mahvash, Arvind Dasari, Philip A. Philip and Michael C. Soulen
      Journal of Nuclear Medicine December 1, 2021, 62 (12) 1669-1671; DOI: https://doi.org/10.2967/jnumed.121.263041

  3. Mankoff, David A.

    1. Building the Bridge: Molecular Imaging Biomarkers for 21st Century Cancer Therapies
      Mark A. Sellmyer, Iris K. Lee and David A. Mankoff
      Journal of Nuclear Medicine December 1, 2021, 62 (12) 1672-1676; DOI: https://doi.org/10.2967/jnumed.121.262484

  4. Mankoff , David

    1. Molecular Imaging Leadership in Academia and Industry
      Mark Mintun and David Mankoff 
      Journal of Nuclear Medicine December 1, 2021, 62 (12) 1657-1659; DOI: https://doi.org/10.2967/jnumed.121.263451

  5. Markowitz, Jeremy

    1. Comparison of the Effect of Three Different Dietary Modifications on Myocardial Suppression in <sup>18</sup>F-FDG PET/CT Evaluation of Patients for Suspected Cardiac Sarcoidosis
      Comparison of the Effect of Three Different Dietary Modifications on Myocardial Suppression in 18F-FDG PET/CT Evaluation of Patients for Suspected Cardiac Sarcoidosis
      Can Özütemiz, Yasemin Koksel, Jerry W. Froelich, Nathan Rubin, Maneesh Bhargava, Henri Roukoz, Rebecca Cogswell, Jeremy Markowitz, David M. Perlman and Daniel Steinberger
      Journal of Nuclear Medicine December 1, 2021, 62 (12) 1759-1767; DOI: https://doi.org/10.2967/jnumed.121.261981

  6. Meagher, Marie

    1. A Phase II, Open-Label Study to Assess Safety and Management Change Using <sup>68</sup>Ga-THP PSMA PET/CT in Patients with High-Risk Primary Prostate Cancer or Biochemical Recurrence After Radical Treatment: The PRONOUNCED Study
      A Phase II, Open-Label Study to Assess Safety and Management Change Using 68Ga-THP PSMA PET/CT in Patients with High-Risk Primary Prostate Cancer or Biochemical Recurrence After Radical Treatment: The PRONOUNCED Study
      Asim Afaq, Heather Payne, Reena Davda, John Hines, Gary J.R. Cook, Marie Meagher, Dimitrios Priftakis, Victoria S. Warbey, Anand Kelkar, Clement Orczyk, Anita Mitra, Sarah Needleman, Michael Ferris, Greg Mullen and Jamshed Bomanji
      Journal of Nuclear Medicine December 1, 2021, 62 (12) 1727-1734; DOI: https://doi.org/10.2967/jnumed.120.257527

  7. Metzenmacher, Martin

    1. Prognostic Value of Postinduction Chemotherapy Volumetric PET/CT Parameters for Stage IIIA or IIIB Non–Small Cell Lung Cancer Patients Receiving Definitive Chemoradiotherapy
      Open Access
      Prognostic Value of Postinduction Chemotherapy Volumetric PET/CT Parameters for Stage IIIA or IIIB Non–Small Cell Lung Cancer Patients Receiving Definitive Chemoradiotherapy
      Maja Guberina, Christoph Pöttgen, Martin Metzenmacher, Marcel Wiesweg, Martin Schuler, Clemens Aigner, Till Ploenes, Lale Umutlu, Thomas Gauler, Kaid Darwiche, Georgios Stamatis, Dirk Theegarten, Hubertus Hautzel, Walter Jentzen, Nika Guberina, Ken Herrmann, Wilfried E.E. Eberhardt and Martin Stuschke
      Journal of Nuclear Medicine December 1, 2021, 62 (12) 1684-1691; DOI: https://doi.org/10.2967/jnumed.120.260646

  8. Meyer, Philipp T.

    1. Assessing Response to <sup>177</sup>Lu-PSMA Radioligand Therapy Using Modified PSMA PET Progression Criteria
      Assessing Response to 177Lu-PSMA Radioligand Therapy Using Modified PSMA PET Progression Criteria
      Kerstin Michalski, Claudius Klein, Tonio Brüggemann, Philipp T. Meyer, Cordula A. Jilg and Juri Ruf
      Journal of Nuclear Medicine December 1, 2021, 62 (12) 1741-1746; DOI: https://doi.org/10.2967/jnumed.120.260836

  9. Michalski, Jeff M.

    1. Improved <sup>223</sup>Ra Therapy with Combination Epithelial Sodium Channel Blockade
      Open Access
      Improved 223Ra Therapy with Combination Epithelial Sodium Channel Blockade
      Diane S. Abou, Amanda Fears, Lucy Summer, Mark Longtine, Nadia Benabdallah, Ryan C. Riddle, David Ulmert, Jeff M. Michalski, Richard L. Wahl, Denise Chesner, Michele Doucet, Nicholas C. Zachos, Brian W. Simons and Daniel L.J. Thorek
      Journal of Nuclear Medicine December 1, 2021, 62 (12) 1751-1758; DOI: https://doi.org/10.2967/jnumed.121.261977

  10. Michalski, Kerstin

    1. Assessing Response to <sup>177</sup>Lu-PSMA Radioligand Therapy Using Modified PSMA PET Progression Criteria
      Assessing Response to 177Lu-PSMA Radioligand Therapy Using Modified PSMA PET Progression Criteria
      Kerstin Michalski, Claudius Klein, Tonio Brüggemann, Philipp T. Meyer, Cordula A. Jilg and Juri Ruf
      Journal of Nuclear Medicine December 1, 2021, 62 (12) 1741-1746; DOI: https://doi.org/10.2967/jnumed.120.260836
« Previous (Pages : 1 2 ... 2) Next »
Back to top

In this issue